Wells Fargo’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-117,000
Closed -$8.08M 7069
2024
Q1
$8.08M Buy
+117,000
New +$7.4M ﹤0.01% 1916
2022
Q4
Sell
-10,000
Closed -$325K 7532
2022
Q3
$325K Hold
10,000
﹤0.01% 3960
2022
Q2
$394K Hold
10,000
﹤0.01% 3879
2022
Q1
$699K Buy
+10,000
New +$731K ﹤0.01% 4160
2021
Q3
Sell
-40,400
Closed -$5.02M 7097
2021
Q2
$5.02M Buy
+40,400
New +$4.82M ﹤0.01% 2869
2020
Q1
Sell
-1,000
Closed -$1K 6350
2019
Q4
$1K Sell
1,000
-200
-17% -$17.6K ﹤0.01% 6245
2019
Q3
$13K Sell
1,200
-600
-33% -$68.4K ﹤0.01% 5885
2019
Q2
$11K Buy
+1,800
New +$181K ﹤0.01% 5898

Other funds holding EXAS

Wells Fargo's EXAS Position: Q1 2026 in Review

Wells Fargo sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 52,183 shares — an estimated $5.3M sold.

Wells Fargo first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $282M in Q2 2020. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Wells Fargo reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Wells Fargo sold 52,183 Exact Sciences shares in Q1 2026, an estimated $5.3M.
  • Wells Fargo first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • Wells Fargo's Exact Sciences position peaked at $282M in Q2 2020.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.